The start-up relios.vision GmbH has developed the SmartContrast software. Using artificial intelligence, it can reduce the dose of contrast agent used in MRI examinations of the brain by two thirds. Co-founder and managing partner Dr. Katerina Deike-Hofmann (Department of Neuroradiology, University Hospital Bonn) and her team colleague Prof. Alexander Effland (Institute of Applied Mathematics, University of Bonn) talk about the many advantages of the software, the different types of support and awards for them as a start-up and about their interdisciplinary collaboration in the video report. An interesting software for many types of MRI devices.
Further exciting articles from the MEDICA-tradefair.com editorial team: